cost of glp 1 drugs in canada GLP-1 surge puts pressure on Canadian drug plans: report what is glp 1 agonist
Description
doi: 10.2337/dc19-1892
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
No serious AEs were reported, followed by a 12-week washout period
In addition, a large-scale clinical study demonstrated that GLP-1 analogues could reduce the mortality of patients with prostate cancer and diabetes (210, 224)
Therapie 2020;75:641-7.ArticlePubMed 12
The secondary endpoints were the percentage change in body weight from baseline to 48 weeks and the presence of weight reduction in 5%, 10%, and 15%
